Skip to main content

Advertisement

Table 3 Galectin-3, HBME-1 and CK19 immunolabelling in the variants of PTC

From: Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential

Variant FVPTC WDT-UMP lesion Papillary microCa Metastatic papillary Ca
Galectin-3 08/13 04/13 09/13 13/13
HBME-1 10/13 10/13 12/13 13/13
CK19 11/13 11/13 11/13 13/13